Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page history shows a new site revision label v3.7.0, replacing the previous v3.6.6. This indicates a system update to the page rendering and history tracking, not a change to study data or content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe history now shows a new revision entry v3.6.6, replacing the previous v3.6.5. This reflects a minor update to the page's history rather than changes to the study content.SummaryDifference0.1%

- Check38 days agoChange DetectedNo additions or deletions are listed for this study history. As a result, there are no textual changes to interpret.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry (v3.6.5) was added on 2026-08-06 with a 'Study Status' note, while the prior revision (v3.6.4) was removed on 2026-05-12.SummaryDifference0.3%

- Check59 days agoChange DetectedRevision: v3.6.4 has been added to the history, replacing the previous v3.6.3. This reflects a platform/UI update to the record history page rather than any substantive change to the trial data.SummaryDifference0.1%

- Check81 days agoChange DetectedThe footer now shows revision v3.6.3, replacing v3.6.2. This reflects a minor update to the record history page interface.SummaryDifference0.1%

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.